Do we really need to clarify that 90% of our accounts are currently active?

2023

Contract expansion to include the creation of language infrastructures and support in  Western, Central and Eastern European languages

2022

Deeply honoured to be leading Europe’s emerging 10 medical translation companies as per Healthcare Business Review (Europe Special edition – July 25, 2022). Click here for more info

2019

Localisation of the Recommendations for a Global Curriculum in Medical Oncology, edition 2016, commissioned by the HESMO (Greek branch of the ESMO)

2018

*Linguistic validation of PRO questionnaire (full translation/validation cycle using independent processes and integrated approach)

2017

*Primary translation/localisation vendor for a UK, top-10 pharmaceutical company

*Primary translation/localisation vendor for a leading Greek CRO company

2016

*Language consultant for a major US pharmaceutical localisation agency

2015

*On-site, front-line language services during an FDA clinical trial inspection

2014

*On-site, front-line language services during an EMA clinical trial inspection

*Contract expansion to include the entire group of companies of a Swiss, top-3 pharmaceutical company

2011

*Language Lead on translation lifecycle for EMA submissions for a major EU localisation agency

*Primary translation/localisation vendor for a Swiss, top-3 pharmaceutical company

2010

*Primary translation/localisation vendor for a leading Greek CRO company

2009

*Primary translation/localisation vendor for an Italian, top-50 pharmaceutical company

2008

*Primary translation/localisation vendor for a Danish, top-20 pharmaceutical company

*Primary translation/localisation vendor for a US, top-5 pharmaceutical company

*Primary translation/localisation vendor for a Greek leading pharma advertising agency

2007

*Primary translation/localisation vendor for a Swiss, top-3 pharmaceutical company

*Primary translation/localisation vendor for a Swiss, top-50 pharmaceutical company

2005

*Full localisation cycle of a disease awareness campaign for a US, top-15 pharmaceutical company